Home › Respiratory Syncytial Virus Infections › California
Pag-aaral pangklinika para sa Respiratory Syncytial Virus Infections sa California
5 pag-aaral para sa Respiratory Syncytial Virus Infections ang naghahanap ng mga kalahok sa mga site sa California.
Opisyal na teksto ng pag-aaral (English)
Remdesivir for the Treatment of Upper Respiratory Tract Infection Due to RSV in Immunocompromised Individuals
- City of Hope Comprehensive Cancer Center, Duarte
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06817889A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease
- LA Universal Research Center, Inc., Los Angeles
- Central Valley Research, Modesto
- Med Partnes, Inc - Elligo- PPDS, Toluca Lake
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07214571A Phase 3 Study of Revaccination in Subsequent Pregnancies With Bivalent RSV Vaccine and Duration of Protection of a Single Dose
- Ronald Reagan UCLA Medical Center, Los Angeles
- Ronald Reagan UCLA Medical Center (inpatient hospital), Los Angeles
- Ronald Reagan UCLA Medical Center, Los Angeles
- at 7 pa
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 0 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06866405A Study of BLB-201 RSV Vaccine in Infants and Children
- Paradigm Clinical Research, La Mesa
- Paradigm Clinical Research - Modesto, Modesto
- University of California, San Diego, San Diego
Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo
6 Months – 5 Years · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05655182Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
- University of California San Francisco, San Francisco
Nagre-recruitPhase 3
3 Days – 2 Years · Lahat ng kasarian · Na-update Peb 9, 2026 · NCT05026749Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.